Matches in Nanopublications for { ?s ?p "[We conducted a randomized, placebo-controlled, double-blind, crossover trial to evaluate whether tomato-derived lycopene supplementation (30 mg/day for 2 mo) decreases serum levels of total IGF-I in premenopausal women with 1) a history of breast cancer (n=24) or 2) a high familial breast cancer risk (n=36).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP193159.RADBh0lfmjwuq6qwU5hyqiED9rovnUkfKdb4g3S29-dY4130_assertion description "[We conducted a randomized, placebo-controlled, double-blind, crossover trial to evaluate whether tomato-derived lycopene supplementation (30 mg/day for 2 mo) decreases serum levels of total IGF-I in premenopausal women with 1) a history of breast cancer (n=24) or 2) a high familial breast cancer risk (n=36).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP193159.RADBh0lfmjwuq6qwU5hyqiED9rovnUkfKdb4g3S29-dY4130_provenance.
- NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_assertion description "[We conducted a randomized, placebo-controlled, double-blind, crossover trial to evaluate whether tomato-derived lycopene supplementation (30 mg/day for 2 mo) decreases serum levels of total IGF-I in premenopausal women with 1) a history of breast cancer (n=24) or 2) a high familial breast cancer risk (n=36).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580074.RAVp0m27yRtBKAcK3B-VzuPDKiqjwjHRR7UwrjhYYV5A4130_provenance.
- NP482107.RARg2hG17A3jDjQEDZ4eXYx27NWrNF49OW24yHSd2KbOQ130_assertion description "[We conducted a randomized, placebo-controlled, double-blind, crossover trial to evaluate whether tomato-derived lycopene supplementation (30 mg/day for 2 mo) decreases serum levels of total IGF-I in premenopausal women with 1) a history of breast cancer (n=24) or 2) a high familial breast cancer risk (n=36).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP482107.RARg2hG17A3jDjQEDZ4eXYx27NWrNF49OW24yHSd2KbOQ130_provenance.
- NP668413.RAXNHAYAvb5NemHRtzUmmDS5vt7gMXVpI97Kod9DUFc30130_assertion description "[We conducted a randomized, placebo-controlled, double-blind, crossover trial to evaluate whether tomato-derived lycopene supplementation (30 mg/day for 2 mo) decreases serum levels of total IGF-I in premenopausal women with 1) a history of breast cancer (n=24) or 2) a high familial breast cancer risk (n=36).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668413.RAXNHAYAvb5NemHRtzUmmDS5vt7gMXVpI97Kod9DUFc30130_provenance.